Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis

Y Zhang, C Zhang, J Shu, J Guo… - Human reproduction …, 2020 - academic.oup.com
ABSTRACT BACKGROUND Despite great advances in assisted reproductive technology,
poor ovarian response (POR) is still considered as one of the most challenging tasks in …

Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis

AK Datta, A Maheshwari, N Felix… - Human reproduction …, 2021 - academic.oup.com
BACKGROUND Mild ovarian stimulation has emerged as an alternative to conventional IVF
with the advantages of being more patient-friendly and less expensive. Inadequate data on …

[HTML][HTML] The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: a …

XL Li, L Wang, F Lv, XM Huang, LP Wang, Y Pan… - Medicine, 2017 - journals.lww.com
Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …

Trends in 'poor responder'research: lessons learned from RCTs in assisted conception

A Papathanasiou, BJ Searle, NMA King… - Human …, 2016 - academic.oup.com
BACKGROUND A substantial minority of women undergoing IVF will under-respond to
controlled ovarian hyperstimulation. These women—so-called 'poor responders'—suffer …

ESHRE guideline: ovarian stimulation for IVF/ICSI

ESHRE Guideline Group on Ovarian … - Human …, 2020 - academic.oup.com
STUDY QUESTION What is the recommended management of ovarian stimulation, based
on the best available evidence in the literature? SUMMARY ANSWER The guideline …

Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis

SK Sunkara, J Pundir, Y Khalaf - Reproductive biomedicine online, 2011 - Elsevier
Many trials have evaluated the use of androgen supplements and androgen-modulating
agents to improve outcome of poor responders undergoing IVF treatment. This study …

ESHRE guideline: ovarian stimulation for IVF/ICSI

TEGGO Ovarian, E Bosch, S Broer… - Human …, 2020 - pubmed.ncbi.nlm.nih.gov
Study question What is the recommended management of ovarian stimulation, based on the
best available evidence in the literature? Summary answer The guideline development …

Management of poor ovarian responders in IVF

FM Ubaldi, L Rienzi, S Ferrero, E Baroni… - Reproductive …, 2005 - Elsevier
Correct controlled ovarian stimulation is of paramount importance in assisted reproductive
technologies. Therefore, analysis of the ovarian reserve of the patient is mandatory to tailor …

GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type

CB Lambalk, FR Banga, JA Huirne… - Human reproduction …, 2017 - academic.oup.com
BACKGROUND Most reviews of IVF ovarian stimulation protocols have insufficiently
accounted for various patient populations, such as ovulatory women, women with polycystic …

Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation

MS Kamath, A Maheshwari… - Cochrane Database …, 2017 - cochranelibrary.com
Background Gonadotropins are the most commonly used medications for controlled ovarian
stimulation in in vitro fertilisation (IVF). However, they are expensive and invasive, and are …